Publications for Thomas Walz
Co-author map based on ISI articles 2007-

Keywords

tyrosine treatment tgf-a tgf-a tgf-<img receptor protein patients mrna melanoma malignant leukemia kinase gene erbb2 cells canertinib cancer breast />

Journal Articles

J Bjohle, J Bergqvist, J S. Gronowitz, H Johansson, L Carlsson, Z Einbeigi, B Linderholm, N Loman, M Malmberg, M Soderberg, M Sundquist, Thomas Walz, M Ferno, J Bergh and T Hatschek
  Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial
  Breast Cancer Research and Treatment, 2013, 139(3), 751-758.

Chikako Suzuki, Lennart Blomqvist, Thomas Hatschek, Lena Carlsson, Zakaria Einbeigi, Barbro Linderholm, Birgitta Lindh, Niklas Loman, Martin Malmberg, Samuel Rotstein, Martin Soderberg, Marie Sundqvist, Thomas Walz, Gunnar Astrom, Hirofumi Fujii, Hans Jacobsson and Bengt Glimelius
  Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy
  Medical Oncology, 2013, 30(1), .

T Hatschek, L Carlsson, Z Einbeigi, E Lidbrink, B Linderholm, B Lindh, N Loman, M Malmberg, S Rotstein, M Soderberg, M Sundquist, Thomas Walz, M Hellstrom, H Svensson, G Astrom, Y Brandberg, John Carstensen, M Ferno and J Bergh
  Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial
  Breast Cancer Research and Treatment, 2012, 131(3), 939-947.
 Web of Science® Times Cited: 4

Emelie Djerf, Cecilia Trinks, Henrik Green, Avni Abdiu, Anna-Lotta Hallbeck, Olle Stål and Thomas Walz
  The pan-ErbB receptor tyrosine kinase inhibitor canertinib promotes apoptosis of malignant melanoma in vitro and displays anti-tumor activity in vivo
  Biochemical and Biophysical Research Communications - BBRC, 2011, 414(3), 563-568.
 Web of Science® Times Cited: 2

Amanda Nordigården, Jenny Zetterblad, Cecilia Trinks, Henrik Green, Pernilla Eliasson, Pia Druid, Kourosh Lotfi, Lars Ronnstrand, Thomas Walz and Jan-Ingvar Jönsson
  Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice
  British Journal of Haematology, 2011, 155(2), 198-208.
   Fulltext  PDF  
 Web of Science® Times Cited: 4

Cecilia Trinks, Emelie A. Severinsson, Birgitta Holmlund, Anna Gréen, Henrik Green, Jan-Ingvar Jönsson, Anna-Lotta Hallbeck and Thomas Walz
  The pan-ErbB tyrosine kinase inhibitor canertinib induces caspase-mediated cell death in human T-cell leukemia (Jurkat) cells
  Biochemical and Biophysical Research Communications - BBRC, 2011, 410(3), 422-427.
 Web of Science® Times Cited: 1

Cecilia Trinks, Emelie Djerf, Anna-Lotta Hallbeck, Jan-Ingvar Jönsson and Thomas Walz
  The pan-ErbB receptor tyrosine kinase inhibitor canertinib induces ErbB-independent apoptosis in human leukemia (HL-60 and U-937) cells
  BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 393(1), 6-10.
 Web of Science® Times Cited: 6

Emelie Djerf, Cecilia Trinks, Avni Abdiu, Lena Thunell, Anna-Lotta Hallbeck and Thomas M Walz
  ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839)
  Melanoma research, 2009, 19(3), 156-166.
 Web of Science® Times Cited: 21

Anna-Lotta Hallbeck, Thomas M. Walz, Åke Wasteson and Annelie Lindström
  Cooperation of endogenous HER-family members in synovial sarcoma cells: stimulation of HER-2/ErbB2 is dependent on EGFR activation
  , 2007, , .

Anna-Lotta Hallbeck, Thomas M. Walz, Kristina Briheim and Åke Wasteson
  TGF-alpha and ErbB2 production in synovial joint tissue: increased expression in arthritic joints
  Scandinavian Journal of Rheumatology, 2005, 34(3), 204-211.
 Web of Science® Times Cited: 22

Lawrence A Wolfraim, Tania M Fernandez, Mizuko Mamura, Walter L Fuller, Rajesh Kumar, Diane E Cole, Stacey Byfield, Angelina Felici, Kathleen C Flanders, Thomas Walz, Anita B Roberts, Peter D Aplan, Frank M Balis and John J Letterio
  Loss of Smad3 in acute T-cell lymphoblastic leukemia
  New England Journal of Medicine, 2004, 351(6), 552-559.
 Web of Science® Times Cited: 78

Larence A Wolfraim, Thomas Walz, Zakiya James, Tania Fernandez and John J Letterio
  p21Cip1 and p27Kip1 act in synergy to alter the sensitivy of naive T cells to TGF-beta-mediated G1 arrest through modulation of IL-2 responsiveness
  Journal of Immunology, 2004, 173, 3093-3102.

Marlene Dressman, Alex Baras, Rachel Malinowski, Lisa Alvis, Irene Kwon, Thomas Walz and Mihael Polymeropoulos
  Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer
  Cancer Research, 2003, 63, 2194-2199.
 Web of Science® Times Cited: 56

MA Dressman, Thomas Walz, C Lavedan, L Barnes, S Buchholtz, I Kwon, MJ Ellis and MH Polymeropoulos
  Genes that co-cluster with estrogen receptor alpha in microarray analysis of breast biopsies.
  The Pharmacogenomics Journal, 2001, 1, 135-141.

Anna-Lotta Hallbeck, Thomas M. Walz and Åke Wasteson
  Interleukin-6 enhances transforming growth factor-alpha mRNA expression in macrophage-like human monocytoid (U-937-1) cells
  Bioscience Reports, 2001, 21(3), 325-339.
 Web of Science® Times Cited: 8

Avni Abdiu, Sven-Erik Larsson, Åke Wasteson and Thomas Walz
  Suramin blocks growth-stimulatory effects of platelet-derived growth factor on malignant fibrous histiocytomas in vitro.
  Cancer Letters, 1999, 146, 189-194.

Avni Abdiu, Sten Wingren, S-E Larsson, Åke Wasteson and Thomas Walz
  Effects of human platelet-derived growth factor-AB on sarcoma growth in vitro and in vivo.
  Cancer Letters, 1999, 141, 39-45.

Conference Articles

T Hatschek, Z Einbeigi, Thomas Walz, M Malmberg, N Loman, L Carlsson, M Soderberg, B Linderholm, B Lindh and M Sundqvist
  Individually dose-adjusted treatment with epirubicin and paclitaxel with or without capecitabine as 1st line treatment in metastatic breast cancer. A randomized multicenter trial in EJC SUPPLEMENTS, vol 8, issue 3, pp 195-196
  EJC SUPPLEMENTS, 2010.


MH Polymeropoulos, A Baras, Thomas Walz, I Kwon and MA Dressman
  Detecting gene amplification in breast cancer by combining Gene expression profiling and Gene mapping.
  American Journal of Human Genetics, 2001.


Ph.D. Theses

Emelie Severinsson
  Experimental studies on ErbB targeted therapy in malignant melanoma
  2012.


  Fulltext PDF

Cecilia Trinks
  Canertinib-induced leukemia cell death signaling: effects of a pan-ERBB inhibitor
  2012.


  Fulltext PDF

Anna-Lotta Hallbeck
  Studies of transforming growth factor alpha in normal and abnormal growth
  2007.


  Fulltext PDF

Thomas M. Walz  Transforming growth factor a in human hematopoietic cells
  1994.